Delivery Order SPE2DB22D3019-SPE2DB25FK4CF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count) with a ceiling value of $14,335.03. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for ultimate completion on July 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Icosapent ethyl is a prescription medication used for cardiovascular health...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $1,118.97. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Icosapent Ethyl 1 Gram Capsules in quantities of 120 units, with a ceiling value of $2,212.37. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count packages) with a ceiling value of $1,779.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. This delivery order is...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $1,302.16 and a period of performance extending through June 25, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $890 delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 3 through July 5, 2023. No additional details were provided regarding the larger vehicle or programs supported through this pharmaceutical procurement. The prime contractor will deliver the requested...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $5,154 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 120 capsules of 1 gram Icosapent Ethyl capsules to be delivered to a location in Conshohocken, Pennsylvania by August 14, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs and maintains medical...
- This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules in quantities of 120s to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price of $2,815.10 and an Ultimate Completion Date of April 19, 2024. The...
- The Defense Logistics Agency awarded a delivery order valued at $452,250 to Amerisourcebergen Drug Corporation for the provision of 120 capsules of 1 gram Icosapent Ethyl capsules. This firm fixed price order is being carried out under the Prime Vendor Program, with performance taking place in Conshohocken, Pennsylvania from August 18-21, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the United States...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4CFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $3,417.46. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies. The IDC serves as a global pharmaceutical support vehicle enabling flexible procurement of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains in support of Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/15/25 |